'Levodopa' presentation slideshows

Benjamin L. Walter M.D. Medical Director, Deep Brain Stimulation Program Neurological Institute

538 views • 39 slides

Drugs for Neurodegenerative Diseases

Drugs for Neurodegenerative Diseases. Kaukab Azim, MBBS, PhD. Drug List. Learning Outcomes. By the end of the course the students will be able to Explain the mechanism of action of each drug in each group Describe the main effects of each drug on different organ systems

1.49k views • 32 slides

Antiparkinson agents

332 views • 14 slides

307 views • 13 slides

Treatment of Parkinson Disease

Treatment of Parkinson Disease. David Tran, 2013 Mercer University PharmD Candidate. Epidemiology. Second to Alzheimer disease as the most common neurodegenerative disorder Men affected more than women Peak onset between 55 and 65 years Occurs in 1% to 2% of individuals older than 60 years

553 views • 13 slides

Moet levodopa-behandeling zo lang mogelijk uitgesteld worden in de ziekte van Parkinson?

Moet levodopa-behandeling zo lang mogelijk uitgesteld worden in de ziekte van Parkinson?. Zijn agonisten beter in het vroege stadium? Is levodopa neurotoxisch?. Agonisten vs. Levodopa.

221 views • 8 slides

Buy Syndopa 275

Buy Syndopa 275 (Levodopa) is converted into dopamine in the brain, a chemical whose low levels cause symptoms of Parkinson’s disease. Carbidopa stops the premature breakdown of Levodopa before it can reach the brain and take effect.

93 views • 8 slides